Current Status of Kidney Replacement Therapy in Türkiye: A Summary of 2022 Turkish Society of Nephrology Registry Report
Main Article Content
Abstract
Background: Turkish Society of Nephrology registry collects data on hemodialysis, peritoneal dialysis, and transplantation annually. Registry reports are printed every year as a booklet, and this is the 33rd year of registry reports. The registry is in close collaboration with international registries.
Methods: In this paper, we summarized data from the 2022 registry report; additionally, we also provided yearly trends of managing end-stage kidney disease.
Results: The number of patients on kidney replacement therapy increases; at the end of 2022, 86 665 patients were on kidney replacement therapy. The prevalence and incidence of end-stage kidney disease were 1016.2 and 160.9 per million population, respectively. Diabetes was the most common cause of end-stage kidney disease. Hemodialysis (71.22%) was the most common type of treatment modality, followed by transplantation (24.68%) and peritoneal dialysis (4.1%).
Conclusion: End-stage kidney disease is a critical and growing health problem for our country. The renal registry of the Turkish Ssociety of Nephrology is one of the leading tools for providing current and sound data on this public health problem.
Cite this article as: Seyahi N, Kocyigit İ, Eren N, et al. Current status of kidney replacement therapy in Türkiye: A summary of 2022 Turkish Society of Nephrology registry report. Turk J Nephrol. 2024;33(2):134-139.